Reagents and additional means for conducting molecular tests with the purchase of equipment by use are purchased.

Reagents and additional means for conducting molecular tests are purchased: identification of the SARS-CoV-2 virus by reverse transcription and real-time PCR method by nucleic acid extraction, studies, about 150 studies; 7 sexually transmitted diseases (7 STDs) studies, about 1,500 studies; Human papillomavirus detection (HPV) tests, about 5,000 tests; Studies for the detection of bacterial pathogens of the upper, lower respiratory tract, about 50 studies; Studies of the causative agents of bacterial infections of the stomach and intestines, about 50 studies.